Akebia Therapeutics (AKBA) Change in Account Payables (2015 - 2026)
Akebia Therapeutics (AKBA) recorded Change in Account Payables of $2.6 million in Q2 2026, down 30.1% from $3.73 million a year earlier.
Powered by 
Analysis
Akebia Therapeutics (AKBA) Change in Account Payables (2015 - 2026) Analysis & Trends
On a TTM basis, Akebia Therapeutics' Change in Account Payables came in at -$3.6 million as of Jun 30, 2026; for FY2025, it was $3.08 million.
- Annual Change in Account Payables has a five-year compound annual growth rate of -3.5% (FY2020 to FY2025).
- Across earlier years, Change in Account Payables came in at -$1.36 million in FY2024, -$5.24 million in FY2023, $1.5 million in FY2022 and -$11.74 million in FY2021.
- Quarterly Change in Account Payables has ranged from -$13.81 million in Q3 2021 to $18.92 million in Q4 2022 over the past five years.
- On a year-over-year basis, Change in Account Payables rose in 1 of the last four quarters, with growth averaging 53.3%.
- Per Business Quant, the preceding three quarters came in at -$7.79 million (Q1 2026), $10.42 million (Q4 2025) and -$8.83 million (Q3 2025).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Change Payables (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,082.65 Bn | 1,051.23 Bn | 19.71 Bn | - |
| 2 | Johnson & Johnson | 623.68 Bn | 542.21 Bn | 17.26 Bn | - |
| 3 | AbbVie | 459.43 Bn | 432.59 Bn | 12.70 Bn | - |
| 4 | Merck | 354.80 Bn | 309.23 Bn | 12.21 Bn | - |
| 5 | Novartis Ag | 269.16 Bn | 225.03 Bn | 11.24 Bn | - |
| 6 | Astrazeneca | 244.40 Bn | 217.97 Bn | 12.86 Bn | - |
| 7 | Amgen | 220.17 Bn | 175.57 Bn | 7.24 Bn | -70.00 Mn |
| 8 | Gilead Sciences | 183.05 Bn | 157.16 Bn | 6.22 Bn | 18.00 Mn |
| 9 | Pfizer | 160.27 Bn | 107.22 Bn | 10.94 Bn | - |
| 10 | Akebia Therapeutics | 236.42 Mn | -433.06 Mn | 38.70 Mn | 2.60 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 2.60 Mn |
| Mar 31, 2026 | -7.79 Mn |
| Dec 31, 2025 | 10.42 Mn |
| Sep 30, 2025 | -8.83 Mn |
| Jun 30, 2025 | 3.73 Mn |
| Mar 31, 2025 | -2.23 Mn |
| Dec 31, 2024 | 2.39 Mn |
| Sep 30, 2024 | -3.03 Mn |
| Jun 30, 2024 | 6.78 Mn |
| Mar 31, 2024 | -7.50 Mn |
| Dec 31, 2023 | 4.50 Mn |
| Sep 30, 2023 | 2.31 Mn |
| Jun 30, 2023 | -3.05 Mn |
| Mar 31, 2023 | -9.01 Mn |
| Dec 31, 2022 | 18.92 Mn |
| Sep 30, 2022 | -8.61 Mn |
| Jun 30, 2022 | -1.45 Mn |
| Mar 31, 2022 | -7.36 Mn |
| Dec 31, 2021 | 3.20 Mn |
| Sep 30, 2021 | -13.81 Mn |
API Access
Akebia Therapeutics Change in Account Payables API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=change-in-account-payables&ticker=AKBA&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "change-in-account-payables", "ticker": "AKBA", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=change-in-account-payables&ticker=AKBA&period=max&api_key=YOUR_API_KEY");
const data = await res.json();